Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model-Reference-Cited by-同舟云学术

Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model

Published:2021-02-17 Issue:3 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Beganovic Maya¹²,Daffinee Kathryn E.¹,Luther Megan K.¹²³,LaPlante Kerry L.¹²³⁴⁵^ORCID

Affiliation:

1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

2. College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA

3. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

4. Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

5. School of Public Health, Brown University, Providence, Rhode Island, USA

Abstract

Acinetobacter baumannii is recognized as an urgent public health threat by the Centers for Disease Control and Prevention (CDC). Current treatment options are scarce, particularly against carbapenem-resistant Acinetobacter baumannii (CRAB).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01680-20

Reference36 articles.

1. Antibiotic resistance threats in the United States, 2019

2. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

3. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

4. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii;Current Opinion in Infectious Diseases;2024-01-04

2. O uso de antimicrobianos na covid-19: uma análise usando a dose diária definida;Health Residencies Journal - HRJ;2023-11-30

3. How to treat severe Acinetobacter baumannii infections;Current Opinion in Infectious Diseases;2023-09-26

4. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

5. Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance;Antibiotics;2023-07-11